A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 05 2023
Historique:
received: 21 06 2022
accepted: 20 04 2023
medline: 18 5 2023
pubmed: 17 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Parkinson's disease (PD) is a complex neurodegenerative disease with etiology rooted in genetic vulnerability and environmental factors. Here we combine quantitative epidemiologic study of pesticide exposures and PD with toxicity screening in dopaminergic neurons derived from PD patient induced pluripotent stem cells (iPSCs) to identify Parkinson's-relevant pesticides. Agricultural records enable investigation of 288 specific pesticides and PD risk in a comprehensive, pesticide-wide association study. We associate long-term exposure to 53 pesticides with PD and identify co-exposure profiles. We then employ a live-cell imaging screening paradigm exposing dopaminergic neurons to 39 PD-associated pesticides. We find that 10 pesticides are directly toxic to these neurons. Further, we analyze pesticides typically used in combinations in cotton farming, demonstrating that co-exposures result in greater toxicity than any single pesticide. We find trifluralin is a driver of toxicity to dopaminergic neurons and leads to mitochondrial dysfunction. Our paradigm may prove useful to mechanistically dissect pesticide exposures implicated in PD risk and guide agricultural policy.

Identifiants

pubmed: 37193692
doi: 10.1038/s41467-023-38215-z
pii: 10.1038/s41467-023-38215-z
pmc: PMC10188516
doi:

Substances chimiques

Pesticides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2803

Subventions

Organisme : NHLBI NIH HHS
ID : F32 HL154644
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES010544
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151684
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 15, 1257–1272 (2016).
pubmed: 27751556
Goldman SM, Musgrove RE, Jewell SA, Di Monte DA. Chapter Three - Pesticides and Parkinson’s Disease: Current Experimental and Epidemiological Evidence. In: Advances in Neurotoxicology (eds Aschner M, Costa LG). Academic Press (2017).
California Department of Pesticide Regulation. Actively Registered Active Ingredients (AI) by Common Name.).
Liu, C. et al. A Scientometric Analysis and Visualization of Research on Parkinson’s Disease Associated With Pesticide Exposure. Front Pub. Health. 8, 91 (2020).
Minakaki, G., Krainc, D. & Burbulla, L. F. The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease. Front. Cell Dev. Biol. 8, 580634 (2020).
pubmed: 33381501 pmcid: 7767856
Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science 357, 1255–1261 (2017).
pubmed: 28882997 pmcid: 6021018
Gonzalez-Rodriguez, P. et al. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature 599, 650–656 (2021).
pubmed: 34732887 pmcid: 9189968
Ryan, S. D. et al. Isogenic human iPSC Parkinson’s model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351–1364 (2013).
pubmed: 24290359 pmcid: 4028128
Cooper, O. et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease. Sci. Transl. Med. 4, 141ra190 (2012).
Khurana, V., Tardiff, D. F., Chung, C. Y. & Lindquist, S. Toward stem cell-based phenotypic screens for neurodegenerative diseases. Nat. Rev. Neurol. 11, 339–350 (2015).
pubmed: 25986505
Kim, T. W. et al. Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use. Cell Stem Cell. 28, 343–355.e345 (2021).
pubmed: 33545081 pmcid: 8006469
Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 480, 547–551 (2011).
pubmed: 22056989 pmcid: 3245796
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
pubmed: 18035408
Ahfeldt, T. et al. Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson’s Disease Discovered Using Isogenic Human Dopaminergic Neurons. Stem Cell Rep. 14, 75–90 (2020).
Cockburn, M. et al. Prostate cancer and ambient pesticide exposure in agriculturally intensive areas in California. Am. J. Epidemiol. 173, 1280–1288 (2011).
pubmed: 21447478 pmcid: 3121318
Ritz, B. R., Paul, K. C. & Bronstein, J. M. Of Pesticides and Men: a California Story of Genes and Environment in Parkinson’s Disease. Curr. Environ. Health Rep. 3, 40–52 (2016).
pubmed: 26857251 pmcid: 5922777
Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E. & Lees, A. J. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42, 1142–1146 (1992).
pubmed: 1603339
Paul, K. C., Cockburn, M., Gong, Y., Bronstein, J. & Ritz, B. Agricultural paraquat dichloride use and Parkinson’s disease in California Central Valley. medRxiv https://doi.org/10.1101/2022.12.28.22284022 (2022).
A.H. Ksehbrosc. PAN Pesticide Database. (ed Network PA) (2014).
Chung, C. Y. et al. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983–987 (2013).
pubmed: 24158904 pmcid: 4022187
Byers, B. et al. SNCA triplication Parkinson’s patient’s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS One. 6, e26159 (2011).
pubmed: 22110584 pmcid: 3217921
Ludtmann, M. H. R. et al. α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease. Nat. Commun. 9, 2293 (2018).
pubmed: 29895861 pmcid: 5997668
Mittal, S. et al. beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson’s disease. Science 357, 891–898 (2017).
pubmed: 28860381 pmcid: 5761666
Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841 (2003).
pubmed: 14593171
Hallacli, E. et al. The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell 185, 2035–2056.e2033 (2022).
pubmed: 35688132 pmcid: 9394447
Hsieh, J. H. et al. Identifying Compounds with Genotoxicity Potential Using Tox21 High-Throughput Screening Assays. Chem. Res. Toxicol. 32, 1384–1401 (2019).
pubmed: 31243984 pmcid: 6740247
Tong, Z. B. et al. Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening. J. Appl. Toxicol. 37, 167–180 (2017).
pubmed: 27143523
Chou, A. P. et al. Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome. J. Biol. Chem. 283, 34696–34703 (2008).
pubmed: 18818210 pmcid: 2596383
Liang, P. et al. Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity. Circulation 127, 1677–1691 (2013).
pubmed: 23519760
Burnett, S. D. et al. Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes. Toxicol. Appl. Pharmacol. 381, 114711 (2019).
pubmed: 31425687 pmcid: 6745256
Uversky, V. N., Li, J., Bower, K. & Fink, A. L. Synergistic Effects of Pesticides and Metals on the Fibrillation of α-Synuclein: Implications for Parkinson’s Disease. NeuroToxicol. 23, 527–536 (2002).
Lam, I. et al. Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions. bioRxiv https://doi.org/10.1101/2022.11.08.515615 (2022).
Nisticò, R., Mehdawy, B., Piccirilli, S. & Mercuri, N. Paraquat- and rotenone-induced models of Parkinson’s disease. Int. J. Immunopathol. Pharmacol. 24, 313–322 (2011).
pubmed: 21658306
McLaughlin, B. A., Nelson, D., Erecińska, M. & Chesselet, M. F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem. 70, 2406–2415 (1998).
pubmed: 9603205
Monzio Compagnoni, G. et al. Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy. Stem Cell Rep. 11, 1185–1198 (2018).
Goldman, S. M. Environmental Toxins and Parkinson’s Disease. Ann. Rev. Pharmacol. Toxicol. 54, 141–164 (2014).
Zhou, T. et al. A hPSC-based platform to discover gene-environment interactions that impact human beta-cell and dopamine neuron survival. Nat. Commun. 9, 4815 (2018).
pubmed: 30446643 pmcid: 6240096
Bisaglia, M. & Bubacco, L. Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant? Biomolecules 10, 195 (2020).
pubmed: 32013126 pmcid: 7072482
Bonneh-Barkay, D., Reaney, S. H., Langston, W. J. & Di Monte, D. A. Redox cycling of the herbicide paraquat in microglial cultures. Mol. Brain Res. 134, 52–56 (2005).
pubmed: 15790529
Franco, R., Li, S., Rodriguez-Rocha, H., Burns, M. & Panayiotidis, M. I. Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson’s disease. Chemico-Biol. Interact. 188, 289–300 (2010).
Gorell, J. M. et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson’s disease. Neurotoxicology 20, 239–247 (1999).
pubmed: 10385887
Lee, J. C., Gray, H. B. & Winkler, J. R. Copper(II) Binding to α-Synuclein, the Parkinson’s Protein. J. Am. Chemical Society. 130, 6898–6899 (2008).
Lindquist, N. G., Larsson, B. S. & Lydén-Sokolowski, A. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin. Neurosci. Lett. 93, 1–6 (1988).
pubmed: 3264893
Shrestha, S. et al. Pesticide use and incident Parkinson’s disease in a cohort of farmers and their spouses. Environ. Res. 191, 110186 (2020).
pubmed: 32919961 pmcid: 7822498
Chen, J., Yu, Q., Patterson, E., Sayer, C. & Powles, S. Dinitroaniline Herbicide Resistance and Mechanisms in Weeds. Front Plant Sci. 12, 634018 (2021).
pubmed: 33841462 pmcid: 8027333
Carvalheiro, M. et al. Trifluralin liposomal formulations active against Leishmania donovani infections. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 71, 292–296 (2009).
Fennell, B. J., Naughton, J. A., Dempsey, E. & Bell, A. Cellular and molecular actions of dinitroaniline and phosphorothioamidate herbicides on Plasmodium falciparum: tubulin as a specific antimalarial target. Mol. Biochem. Parasitol. 145, 226–238 (2006).
pubmed: 16406111
Giles, N. L., Armson, A. & Reid, S. A. Characterization of trifluralin binding with recombinant tubulin from Trypanosoma brucei. Parasitol Res. 104, 893–903 (2009).
pubmed: 19050925
Fernandes, T. C. C., Pizano M. A. & Marin-Morales, M A. Characterization, Modes of Action and Effects of Trifluralin: A Review. Ch. 19. https://doi.org/10.5772/55169 (2013).
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G. & Anandatheerthavarada, H. K. Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089–9100 (2008).
pubmed: 18245082 pmcid: 2431021
Greene, J. C. et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. 100, 4078–4083 (2003).
pubmed: 12642658 pmcid: 153051
Park, J. et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157–1161 (2006).
pubmed: 16672980
Roy, S. & Wolman, L. Ultrastructural observations in Parkinsonism. J. Pathology. 99, 39–44 (1969).
Ritz, B. & Costello, S. Geographic model and biomarker-derived measures of pesticide exposure and Parkinson’s disease. Ann. N. Y. Acad. Sci. 1076, 378–387 (2006).
pubmed: 17119217 pmcid: 3656600
Guttikonda, S. R. et al. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer’s disease. Nat. Neurosci. 24, 343–354 (2021).
pubmed: 33558694 pmcid: 8382543
Vatine, G. D. et al. Human iPSC-Derived Blood-Brain Barrier Chips Enable Disease Modeling and Personalized Medicine Applications. Cell Stem Cell. 24, 995–1005.e1006 (2019).
pubmed: 31173718
Mitchell, J. M. et al. Mapping genetic effects on cellular phenotypes with “cell villages”. bioRxiv https://doi.org/10.1101/2020.06.29.174383 (2020).
Cederquist, G. Y. et al. A Multiplex Human Pluripotent Stem Cell Platform Defines Molecular and Functional Subclasses of Autism-Related Genes. Cell Stem Cell. 27, 35–49.e36 (2020).
pubmed: 32619517 pmcid: 7376579
California Department of Water Resources Land Use Surveys. In: CDWR) (2013).
McElroy, J. A., Remington, P. L., Trentham-Dietz, A., Robert, S. A. & Newcomb, P. A. Geocoding addresses from a large population-based study: lessons learned. Epidemiology 14, 399–407 (2003).
pubmed: 12843762
Tomishima M. Midbrain dopamine neurons from hESCs. In: StemBook) (2008).
Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. 109, E1848–E1857 (2012).
pubmed: 22645348 pmcid: 3390875

Auteurs

Kimberly C Paul (KC)

Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. kimberlp@ucla.edu.

Richard C Krolewski (RC)

Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Edinson Lucumi Moreno (E)

Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.

Jack Blank (J)

Prime Medicine, Inc, Cambridge, MA, USA.

Kristina M Holton (KM)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Tim Ahfeldt (T)

Recursion Pharmaceuticals, Salt Lake City, UT, USA.
Nash Family Department of Neuroscience at Mount Sinai, New York, NY, USA.

Melissa Furlong (M)

University of Arizona, Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.

Yu Yu (Y)

UCLA Center for Health Policy Research, Los Angeles, CA, USA.

Myles Cockburn (M)

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Laura K Thompson (LK)

Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Alexander Kreymerman (A)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Elisabeth M Ricci-Blair (EM)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Yu Jun Li (YJ)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Heer B Patel (HB)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Richard T Lee (RT)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Harvard Stem Cell Institute, Cambridge, MA, USA.
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis St, Boston, MA, 02115, USA.

Jeff Bronstein (J)

Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.

Lee L Rubin (LL)

Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. lee_rubin@harvard.edu.
Harvard Stem Cell Institute, Cambridge, MA, USA. lee_rubin@harvard.edu.

Vikram Khurana (V)

Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA. vkhurana@bwh.harvard.edu.
Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. vkhurana@bwh.harvard.edu.

Beate Ritz (B)

Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. britz@ucla.edu.
Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA. britz@ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH